Carl-Henrik Heldin is Professor in Molecular Cell Biology at Uppsala University and member of the SciLifeLab Faculty. He obtained his PhD degree in Medical and Physiological Chemistry in 1980 at the University of Uppsala, where he continued to work until 1985 using a position sponsored by the Swedish Cancer Society. In 1986 he became Branch Director of the Ludwig Institute for Cancer Research in Uppsala, Sweden, and is since 1992 also professor in Molecular Cell Biology at Uppsala University.
Carl-Henrik Heldin has been or is a member of Scientific Advisory Boards of several institutes and companies, including the European Molecular Biology Laboratory and the German Cancer Center in Heidelberg, the Center for Molecular Medicine in Vienna and the Finnish Institute for Molecular Medicine in Helsinki. He served as Vice President of the European Research Council until 2014 and is the chair of the Board of the Nobel Foundation. He has also been elected chair of the European Molecular Biology Organization. Carl-Henrik Heldin has received many academic honors and awards and his research has been well cited by researchers around the world.
“I am very proud of being elected for this position”, said Carl-Henrik Heldin. “SciLifeLab is an important infrastructure for molecular biosciences in Sweden as well as an internationally competitive and vital multidisciplinary research environment. I am looking forward to be a part of the future development of the center.”
For more information contact:
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.